1. Johnson, E. M. (1980). Screening for teratogenic potential: are we asking the proper question? Teratology, 21, 259
2. Nelson, M. M. (1955). Mammalian fetal development and antimetabolites. In Antimetabolites and Cancer, American Association for the Advancement of Science, New York, pp. 107–128
3. Kalter, H. and Warkany, J. (1959). Experimental production of congenital malformations by metabolic procedure. Physiol. Rev., 39, 69–115
4. Johnson, E. M. and Nelson, M. M. (1959). Morphological changes in embryonic development resulting from transitory pteroylglutamic acid (PGA) deficiency early in pregnancy. Anat. Rec., 133, 294
5. Johnson, E. M., Nelson, M. M. and Monie, I. W. (1963). Effects of transitory pteroylglutamic acid (PGA) deficiency on embryonic and placental development in the rat. Anat. Rec., 146, 215–224